Showing posts with label genetic. Show all posts
Showing posts with label genetic. Show all posts

Monday, 19 August 2013

Researchers link PRKG1 genetic mutation to thoracic aortic disease

Main Category: Heart Disease
Also Included In: Genetics
Article Date: 19 Aug 2013 - 1:00 PDT Current ratings for:
Researchers link PRKG1 genetic mutation to thoracic aortic disease
not yet ratednot yet rated

A multi-institutional team led by Dianna Milewicz, M.D., Ph.D., of The University of Texas Health Science Center at Houston (UTHealth) has found a recurrent genetic mutation that has been linked to deadly thoracic aortic dissections in family members as young as 17 years of age.

The gene known as PRKG1 makes a protein called cGMP-dependent kinase, type I. The PRKG1 mutation alters the function of the protein and causes the muscle cells in the wall of the aorta to respond incorrectly to pulsatile blood flow from the heart, and the change in this one protein ultimately causes thoracic aortic aneurysm and acute aortic dissection. The mutation was identified in four families, including three in the United States. The majority of the affected family members suffered acute aortic dissections at young ages (17 to 51 years).

"What is unique about this finding is that we identified four unrelated families from around the world and of different ethnicities who have the exact same genetic mutation, which is one altered base pair out of the 3 billion base pairs that make up our DNA," said Milewicz, senior author of the study. "The protein is normally regulated but this mutation causes the protein to be always active, almost like the brakes have gone out on a car and it cannot stop." The study was published in the online issue of the American Journal of Human Genetics. Milewicz is professor and director of the Division of Genetics at the UTHealth Medical School and holds the President George H.W. Bush Chair in Cardiovascular Research. She is also on the faculty of The University of Texas Graduate School of Biomedical Sciences and director of the John Ritter Research Program in Aortic and Vascular Disease.

For families in the study, knowing who carries the gene defect could help them make important medical decisions.

"The fact we will have a positive identification gives us a clearer picture of what to do next," said Stephen Harris of Montana, who lost one of his four daughters to the disease. "If my daughters are not carrying the gene defect, it gives them more freedom to have a baby. And they can make a decision about whether to have elective surgery sooner."

In thoracic aortic disease, the wall of the aorta, the main blood vessel leading out of the heart, weakens and forms an aneurysm that can ultimately lead to an aortic dissection and death. There are few symptoms until the aorta begins to dissect, or tear, requiring emergency surgery. Thoracic aortic aneurysms and dissections are familial in up to 20 percent of all cases. Researchers have now discovered nine different genes linked to familial thoracic aortic disease. Family members who have inherited the mutated gene will need to be monitored by a cardiologist, undergo regular imaging of the aorta and take medications to control high blood pressure and reduce the stress on the aorta. When the aorta enlarges to a certain size, elective surgery can be performed in order to avoid emergency repair to attempt to repair a catastrophic aortic dissection or rupture. . Using this management protocol, acute aortic dissections and the associated premature deaths can be prevented.

Stephen Harris' brother was the first to have symptoms of an aortic dissection when he was 51 years old and was found to have a descending thoracic aortic dissection. Cheryl Harris, Stephen's wife, said their daughter Jenny was eight months pregnant in 2006 when she began to have severe pain in her back just like her uncle but since aortic disease mostly affects older men, they didn't connect it to her. She died suddenly six days later from a dissected aorta and the baby also did not survive. In June of 2012, daughter Andra Arterbury, then 27, felt the classic symptom of extreme back pain, which radiated into her neck. She insisted on a scan at the hospital emergency room and went immediately to life-saving surgery when it showed that the aorta was dissected up into her carotid artery and down nearly to her groin.

Steve Harris traveled to Houston to consult with Milewicz and the clinical team at the Multidisciplinary Aortic and Vascular Disease Clinic. He was also found to have aortic root dilation and because of his family history of early thoracic aortic dissections at diameters smaller than 5 centimeters, he elected to have surgery. In October 2012, Anthony Estrera, M.D., associate professor of cardiovascular surgery at the UTHealth Medical School and the Memorial Hermann Heart and Vascular Institute, performed the graft replacement of his aortic root.

Wendy Amaya, 40, of Albuquerque and her family members have also suffered from the disease. Her mother, 43; brother, 35; and nephew, 23, all died from thoracic aortic dissections. Her 19-year-old son required surgery to repair a dissection in 2012 and another son has an aneurysm that is being monitored. Amaya had surgical repairs for her aorta in 2004 and 2012.

"The imaging is expensive, so it's important to find out if they have the genetic mutation. I have younger children and nieces and nephews," Amaya said. Now that the causative genetic mutation has been identified, genetic testing can identify family members who carry the familial mutation and need aortic surveillance.

Of the individuals who have the mutation, 63 percent had acute aortic dissections and 37 percent have aortic root enlargement. Of the 19 family members with dissections, five had a diagnosis of hypertension and five had evidence of damage associated with hypertension such as left ventricular hypertrophy or chronic small vessel cerebrovascular disease.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our heart disease section for the latest news on this subject.

Recurrent Gain-of-Function Mutation in PRKG1 Causes Thoracic Aortic Aneurysms and Acute Aortic Dissections

The American Journal of Human Genetics, Volume 93, Issue 2, 398-404, 01 August 2013 doi:10.1016/j.ajhg.2013.06.019

First author of the paper is Dong-chuan Guo, Ph.D., assistant professor of genetics at UTHealth. Co-authors from UTHealth are Ellen Regalado, M.S., genetic counselor and instructor; Limin Gong, assistant professor; and Guijuan Ghang, M.D., postdoctoral fellow.

Co-authors and investigators throughout world include Darren Casteel, Ph.D., of the University of California at San Diego; Guillaume Jondeau and Catherine Boileau from the Institut National de la Sante et de la Recherche Medicále of France; Jay Shendure, Mark J. Rieder, Michael J. Bamshad and Deborah Nickerson, Ph.D., from the University of Washington; Suzanne Leal, Ph.D., Regie Santos-Cortez, M.D., Ph.D., Joseph Coselli, M.D., and Choel Kim, Ph.D., from Baylor College of Medicine; Sarah Dyack and S. Gabrielle Horne, from Dalhousie University, Halifax, Nova Scotia, Canada; and the GenTAC Registry Consortium (HHSN268200648199C and HHSN268201000048C).

Funding for the research came from the National Heart, Lung and Blood Institute (NHLBI) (R01 HL62594 and P50HKL083794-01), part of the National Institutes of Health; the Vivian L. Smith Foundation; and the Tex-Gen Foundation. French and European sources provided funding for the Paris investigators. Support was also received from the NHLBI GO Exome Sequencing Project (HL-102926).

University of Texas Health Science Center at Houston

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

University of Texas Health Science Center at Houst. "Researchers link PRKG1 genetic mutation to thoracic aortic disease." Medical News Today. MediLexicon, Intl., 19 Aug. 2013. Web.
19 Aug. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Researchers link PRKG1 genetic mutation to thoracic aortic disease'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Friday, 16 August 2013

Leap in survival rates for childhood leukaemia patients with rare genetic abnormality

Main Category: Lymphoma / Leukemia / Myeloma
Article Date: 15 Aug 2013 - 2:00 PDT Current ratings for:
Leap in survival rates for childhood leukaemia patients with rare genetic abnormality
not yet ratednot yet rated

A pioneering genetic study means that children with a rare subtype of leukaemia have 75% less chance of their leukaemia recurring.

A study by Newcastle University scientists, published online on August 12th in the Journal of Clinical Oncology, has shown that lives have already been saved as a result of identifying children carrying a chromosomal abnormality known as iAMP21 and giving these patients a very intensive treatment regimen.

Overall survival for acute lymphoblastic leukaemia (ALL) patients, a cancer of the white blood cells, is now very high, with up to 90% of children being cured. A minority of patients, however, still do not respond to standard treatment.

A decade ago, the same scientists, funded by the blood cancer charity Leukaemia & Lymphoma Research, discovered the genetic error known as iAMP21. This abnormality occurs when parts of chromosome 21 - one of 23 pairs of chromosomes that contain our genetic instructions - are copied and shuffled around, resulting in extra copies of some genes. The researchers found that this abnormality was present in around 2% of children diagnosed with ALL and that it gave them a much greater chance of suffering a relapse.

The team, led by Professor Christine Harrison and Professor Anthony Moorman from the Leukaemia Research Cytogenetics Group, tracked the progress of patients with iAMP21 using samples from clinical trials between 1997 and 2002. They found that more than 80% of patients with iAMP21 had relapsed, compared to less than for 25% for children overall. The long-term survival for the iAMP21 group was also much lower.

Since 2003, bone marrow samples from every child diagnosed with ALL have been tested for the presence of iAMP21 using a genetic test known as 'fluorescence in situ hybridisation' (FISH), which binds glowing tags to DNA and "lights-up" the abnormal sequences. Children with iAMP21 registered on the UKALL2003 trial, which was funded by Leukaemia & Lymphoma Research and the Medical Research Council, were immediately recommended for treatment using a very intensive protocol.

The results of the UKALL2003 trial show that if children with iAMP21 are treated with intensive chemotherapy they have a dramatically reduced risk of relapse. In addition the proportion surviving for five years or more increased to nearly 90%.

Anthony Moorman, Professor of Genetic Epidemiology at Newcastle University, said: "Although using the presence of genetic abnormalities to guide treatment is not new within childhood leukaemia, such a clear demonstration of its beneficial impact on survival is extremely rare. In time we may be able to design drugs to actually target the iAMP21 abnormality, sparing these children from toxic treatment."

Professor Chris Bunce, Research Director at Leukaemia & Lymphoma Research, said: "By establishing how different genetic abnormalities found in leukaemia cells dictate how well the child will respond to treatment, we can identify high-risk patients early on. These new results demonstrate the huge potential of personalised medicine."

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our lymphoma / leukemia / myeloma section for the latest news on this subject.

The report is published online in the Journal of Clinical Oncology under the title, ‘Risk directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukaemia and intrachromosomal amplification of chromosome 21: A comparison of MRC ALL97/99 and UKALL2003 trials’. Principal authors: Prof Anthony V Moorman, Professor Ajay Vora and Prof Christine J Harrison, Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, UK, doi: 10.1200/JCO.2013.48.9377

Newcastle University

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

University, Newcastle. "Leap in survival rates for childhood leukaemia patients with rare genetic abnormality." Medical News Today. MediLexicon, Intl., 15 Aug. 2013. Web.
15 Aug. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Leap in survival rates for childhood leukaemia patients with rare genetic abnormality'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Mediterranean diet 'reduces genetic stroke risk'

Featured Article
Academic Journal
Main Category: Stroke
Also Included In: Nutrition / Diet;  Diabetes
Article Date: 15 Aug 2013 - 8:00 PDT Current ratings for:
Mediterranean diet 'reduces genetic stroke risk'
3 and a half stars4 stars

Scientists say they have discovered that the Mediterranean diet may prevent a genetic risk of stroke since it appears to interact with a particular gene variant usually associated with type 2 diabetes.

Researchers from the Jean Mayer USDA Human Nutrition Research center on Aging (USDA HNRCA) at Tufts University, and the CIBER Fisiopatología de la Obesidad y Nutricion in Spain, conducted the study, which was published in the journal Diabetes Care.

The research team analyzed 7,018 men and women involved in the Prevencion con Dieta Mediterranea (PREDIMED) trial. The trial, carried out over a 5-year period, looked at whether a Mediterranean or a low-fat controlled diet had an effect on the risk of cardiovascular disease, stroke and heart attack, and whether genetics played a part in this.

Prior to the trial, participants were also required to complete food frequency questionnaires, in order to see how closely participants followed a Mediterranean diet.

The study focused on a particular variant found in the Transcription Factor 7-like 2 (TCF7L2) gene. The variant is commonly involved in glucose metabolism and can lead to the development of type 2 diabetes. The researchers say this gene variant's link to heart disease has previously been unclear.

Around 14% of the PREDIMED participants were found to be homozygous carriers, meaning they possessed two copies of this gene variant.

Of these homozygous participants who were also following the Mediterranean diet, results of the analysis revealed a reduced number of strokes. José Ordovás, director of the Nutrition and Genomics Laboratory at the USDA HNRCA, explains:

"Being on the Mediterranean diet reduced the number of strokes in people with two copies of the variant.

The food they ate appeared to eliminate any increased stroke susceptibility, putting them on an even playing field with people with one or no copies of the variant."

However, Ordovás adds that homozygous carriers who were following the low-fat diet did not have the same results, with a three times increased risk of having a stroke compared with participants with only one or no copies of the gene variant.

Delores Corella, of the CIBER Fisiopatologia de la Obesidad y Nutrici?n, says, however, results showed that when adherence to the Mediterranean diet was high, having two copies of the gene variant bared no significance on fasting glucose levels.

She adds:

"The same was true for three common measures of cardiovascular disease risk: total blood cholesterol, low density lipoprotein and triglycerides."

"Conversely, these risk factors were considerably higher in homozygous carriers with low adherence to the diet."

Previous research has also revealed that following a Mediterranean diet can benefit health. A study from the University of Alabama at Birmingham suggested that following a Mediterranean diet may improve memory and thinking.

Researchers from Spain have suggested the diet may help protect the health of bones.

The Mayo Clinic offers a recommendation of key components that make up a healthy Mediterranean diet. These include:

Eating primarily plant-based foods, such as fruit, vegetables, whole grains, legumes and nutsReplacing butter with healthy fats, such as olive oilUsing herbs and spices instead of salt to flavor foodsLimiting red meat to no more than a few times a monthDrinking red wine in moderation (optional).

The researchers in the current Spanish study would like to see more studies to determine how our genes and the Mediterranean diet work together.

Written by Honor Whiteman


Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today Visit our stroke section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Whiteman, Honor. "Mediterranean diet 'reduces genetic stroke risk'." Medical News Today. MediLexicon, Intl., 15 Aug. 2013. Web.
15 Aug. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Mediterranean diet 'reduces genetic stroke risk''

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Thursday, 15 August 2013

Potential to repair any genetic defect offered by new gene repair technique

Main Category: Genetics
Article Date: 14 Aug 2013 - 1:00 PDT Current ratings for:
Potential to repair any genetic defect offered by new gene repair technique
5 starsnot yet rated

Using human pluripotent stem cells and DNA-cutting protein from meningitis bacteria, researchers from the Morgridge Institute for Research and Northwestern University have created an efficient way to target and repair defective genes.

Writing in the Proceedings of the National Academy of Sciences, the team reports that the novel technique is much simpler than previous methods and establishes the groundwork for major advances in regenerative medicine, drug screening and biomedical research.

Zhonggang Hou of the Morgridge Institute's regenerative biology team and Yan Zhang of Northwestern University served as first authors on the study; James Thomson, director of regenerative biology at the Morgridge Institute, and Erik Sontheimer, professor of molecular biosciences at Northwestern University, served as principal investigators.

"With this system, there is the potential to repair any genetic defect, including those responsible for some forms of breast cancer, Parkinson's and other diseases," Hou said. "The fact that it can be applied to human pluripotent stem cells opens the door for meaningful therapeutic applications."

Zhang said the Northwestern University team focused on Neisseria meningitidis bacteria because it is a good source of the Cas9 protein needed for precisely cleaving damaged sections of DNA.

"We are able to guide this protein with different types of small RNA molecules, allowing us to carefully remove, replace or correct problem genes," Zhang said. "This represents a step forward from other recent technologies built upon proteins such as zinc finger nucleases and TALENs."

These previous gene correction methods required engineered proteins to help with the cutting. Hou said scientists can synthesize RNA for the new process in as little as one to three days - compared with the weeks or months needed to engineer suitable proteins.

Thomson, who also serves as the James Kress Professor of Embryonic Stem Cell Biology at the University of Wisconsin-Madison, a John D. MacArthur professor at UW-Madison's School of Medicine and Public Health and a professor in the department of molecular, cellular and developmental biology at the University of California, Santa Barbara, says the discovery holds many practical applications.

"Human pluripotent stem cells can proliferate indefinitely and they give rise to virtually all human cell types, making them invaluable for regenerative medicine, drug screening and biomedical research," Thomson says. "Our collaboration with the Northwestern team has taken us further toward realizing the full potential of these cells because we can now manipulate their genomes in a precise, efficient manner."

Sontheimer, who serves as the Soretta and Henry Shapiro Research Professor of Molecular Biology with Northwestern's department of molecular biosciences, Center for Genetic Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, says the team's results also offer hopeful signs about the safety of the technique.

"A major concern with previous methods involved inadvertent or off-target cleaving, raising issues about the potential impact in regenerative medicine applications," he said. "Beyond overcoming the safety obstacles, the system's ease of use will make what was once considered a difficult project into a routine laboratory technique, catalyzing future research."

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our genetics section for the latest news on this subject.

Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis

Also contributing to the study, which was supported by funding from sources including the National Institutes of Health, the Wynn Foundation and the Morgridge Institute for Research, were Nicholas Propson, Sara Howden and Li-Fang Chu from the Morgridge Institute for Research.

Zhonggang Hou, Yan Zhang, Nicholas E. Propson, Sara E. Howden, Li-Fang Chu, Erik J. Sontheimer, and James A. Thomson. PNAS 2013 ; published ahead of print August 12, 2013, doi:10.1073/pnas.1313587110

University of Wisconsin-Madison

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

University of Wisconsin-Madison. "Potential to repair any genetic defect offered by new gene repair technique." Medical News Today. MediLexicon, Intl., 14 Aug. 2013. Web.
14 Aug. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Potential to repair any genetic defect offered by new gene repair technique'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Monday, 5 August 2013

Wild type genetic background affects outcome even for diseases with a simple genetic basis

Main Category: Genetics
Article Date: 05 Aug 2013 - 0:00 PDT Current ratings for:
Wild type genetic background affects outcome even for diseases with a simple genetic basis
not yet ratednot yet rated

If two women have the same genetic mutation that puts them at higher-than-average risk for a disease such as breast cancer, why does only one develop the disease?

In the current issue of PLOS Genetics, Michigan State University genetic scientists have begun to understand how the rest of the genome interacts with such mutations to cause the differences we see among individuals.

"It's been known for a while that genetic mutations can modify each other's effects," said Ian Dworkin, MSU associate professor of zoology and co-author of the paper. "And we also know that the subtle differences in an individual's genome - what scientists call wild type genetic background - also affects how mutations are manifested."

Dworkin and Sudarshan Chari, zoology doctoral student and the paper's lead author, wanted to know how common it was for wild type genetic background to alter the way genetic mutations interact with each other. This is the first time that it's been examined in a systematic manner, Dworkin added.

Using the fruit fly genome, the researchers found that wild type genetic background affected the outcomes of interactions between genetic mutations about 75 percent of the time. This could have huge implications in how scientists construct genetic networks - maps of how genes interact with each other.

"It may be that some crucial portions of genetic networks are missing," he said. "It also seems that network descriptions are more fluid than we thought."

Fruit flies have been called humans with wings, genetically speaking, due to their similarities. By focusing on wings and a genetic mutation that alters them, the researchers demonstrated the influence of wild type genetic background was actually quite common.

The broader implication for humans is that even for diseases with a simple genetic basis, variation in the genome may matter for both understanding and treatment, Dworkin said.

This new insight explains how, in an example like breast cancer, every woman's genetic background is likely influencing how the mutation is expressed, causing different disease outcomes. The research also may help explain why some people benefit from a specific treatment for a disease, while others get no benefits or become resistant to a drug after a short time.

It's likely that most diseases with a suspected genetic component, such as cancer, asthma or Parkinson's, involve reactions between more than one set of genes. For Dworkin and Chari, the next step is to tease apart the intricacies of what's happening.

"Is it just the two pairs of genes that are interacting?" Dworkin asked. "Or is it that the two genes are interacting and then many other genes are modifying that reaction? This will help us understand how much complexity is involved."

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our genetics section for the latest news on this subject.

The research is funded by the National Science Foundation grant number MCB 0922344.

Michigan State University

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

University, Michigan State. "Wild type genetic background affects outcome even for diseases with a simple genetic basis." Medical News Today. MediLexicon, Intl., 5 Aug. 2013. Web.
5 Aug. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Wild type genetic background affects outcome even for diseases with a simple genetic basis'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Thursday, 1 August 2013

Identification of genetic mutation linked to congenital heart disease

Main Category: Heart Disease
Also Included In: Genetics
Article Date: 31 Jul 2013 - 0:00 PDT Current ratings for:
Identification of genetic mutation linked to congenital heart disease
not yet ratednot yet rated

A mutation in a gene crucial to normal heart development could play a role in some types of congenital heart disease - the most common birth defect in the U.S. The finding, from a team in The Research Institute at Nationwide Children's Hospital, could help narrow the search for genes that contribute to this defect, which affects as many as 40,000 newborns a year. The findings were published in a recent issue of in Human Mutation.

Several hundred genes have been implicated in the formation of the heart, and a mutation in any of them could potentially contribute to a cardiac defect. Identifying which of these genes is involved in human congenital heart disease has been a challenge for scientists in the field, says Vidu Garg, MD, senior author of the new study, principal investigator in the Center for Cardiovascular and Pulmonary Research and director of Translational Research in The Heart Center at Nationwide Children's.

"We have to ask ourselves, what subset of the more than 20,000 genes that make up the human genome are contributing to congenital heart disease?" he says. "Right now, we don't know enough about a lot of those genes, so this study provides another piece of the puzzle."

That piece is FOXP1, a member of a large gene family that helps regulate tissues throughout the body, including in the heart, lungs and brain. A few studies on FOXP1 had described its function and role in cardiac development in animal models, but it wasn't until a former colleague called with an interesting case that Dr. Garg decided the gene was worth a closer look.

While analyzing a DNA sample from an 8-month-old infant who died from complications of complex congenital heart disease, Linda Baker, MD, at the University of Texas Southwestern Medical Center, had found a rare genetic abnormality - a small chromosomal deletion - in the patient's FOXP1 gene.

A search of DNA samples from patients with congenital heart disease in a repository at Nationwide Children's - one of the largest in the nation - revealed two additional patients with a similar complex heart defect who had a rare mutation in the same gene. On further analysis, Dr. Garg's team found that this mutation affected the gene's ability to express a transcription factor called Nkx2.5, which has been implicated in congenital heart disease.

"If you have three unrelated people with an abnormality in the same gene, and they also have an extremely rare type of congenital heart disease, there's a high likelihood that the gene is contributing to the condition," says Dr. Garg, who also is an associate professor of pediatrics at The Ohio State University College of Medicine. "Understanding how either deletion or loss of FOXP1 affects normal heart development could help contribute to our understanding of congenital heart disease."

The next step in the research is to see if they can find the FOXP1 mutation in patients with different types of congenital heart disease. From there, they will begin to look at how the gene interacts with others involved in the formation of a normal heart. Given that congenital heart disease is probably the result of mutations in many genes, Dr. Garg says, it's quite possible that by studying this gene and its potential partners, we can uncover other potential candidate genes for heart malformations.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our heart disease section for the latest news on this subject.

Chang, S.-W., Mislankar, M., Misra, C., Huang, N., DaJusta, D. G., Harrison, S. M., McBride, K. L., Baker, L. A. and Garg, V. (2013), Genetic Abnormalities in FOXP1 Are Associated with Congenital Heart Defects. Hum. Mutat.. doi: 10.1002/humu.22366

Nationwide Children's Hospital

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Hospital, Nationwide Children\'s. "Identification of genetic mutation linked to congenital heart disease." Medical News Today. MediLexicon, Intl., 31 Jul. 2013. Web.
31 Jul. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Identification of genetic mutation linked to congenital heart disease'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Friday, 26 July 2013

Greater success in personalized medicine class by students who underwent genetic testing

Main Category: Medical Students / Training
Also Included In: Genetics
Article Date: 25 Jul 2013 - 0:00 PDT Current ratings for:
Greater success in personalized medicine class by students who underwent genetic testing
not yet ratednot yet rated

Students who had their genome tested as part of a groundbreaking medical school course on personalized medicine improved their knowledge of the class materials by an average of 31 percent compared with those who didn't undergo the testing, according to a study by researchers at the Stanford University School of Medicine.

While the sample size was small - 23 students sent their saliva to a commercial genetics testing company; eight did not - the results may encourage educators to consider this approach in the future, the authors said.

"These results indicate that learning principles of human genetics is more powerful, and learning is more sustained, when exploring your own data," said Keyan Salari, MD, PhD, a former Stanford student who initially proposed the course, called "Genomics and Personalized Medicine." Salari, who is the lead author of the study, is now a urology resident at the Massachusetts General Hospital in Boston. The study was published in PLOS ONE.

The eight-week elective course was the first in the country to give students in advanced-degree programs the option of personal genotyping as part of the curriculum. It was designed to teach them how the explosion of knowledge about genetics over the past 10 years could affect the treatment of patients. Since the course was first offered in 2010, the use of genetic testing in clinical care has grown.

The course, which is still being taught, was designed as a way to train future doctors and scientists in the skills necessary to use this new tool. The study, which was based on a pre- and post-course survey taken voluntarily by the majority of the students in the class, also showed that personal testing and the use of personal genotype data in the classroom did not appear to cause significant anxiety.

"This was a novel teaching approach," said Kelly Ormond, co-author of the study and associate professor of genetics. "There is always a lot of interest in whether personalized learning can influence education. ... What our study shows is that it might have benefits for some self-selected students, and is worthy of cautious consideration."

Initially controversial, the course was only approved after a campus task force met regularly for a year to debate the pros and cons of students undergoing genetic testing as part of a class. A number of concerns were raised, including the possible anxiety of learning they could be more susceptible to certain diseases, such as diabetes or Parkinson's. A number of safeguards were subsequently included as part of the course plan, including complete anonymity as to which students chose to undergo testing.

Salari conceived of the idea for the course in 2009 as a PhD student in genetics. He was working as a teaching assistant in the first-year human genetics course for medical students. At the time, the course curriculum consisted primarily of traditional genetics and didn't reflect the genomics revolution of the past 10 years. Salari had also recently undergone his own genetic testing, and saw the educational benefits.

"I was curious about what stories were hidden in my genome, what health risks, what responses to drugs that might be predicted," Salari said. "For instance, I learned I might have a higher risk for age-related macular degeneration. That led me to read and learn a lot more about the genetics of that disease than I probably would have otherwise."

He added: "I wanted to find a way to translate my passion for genomics to all these medical students."

Study results also showed that 83 percent of students who chose to undergo testing were pleased with their decision. Seventy percent of those who underwent the testing reported a better understanding of human genetics on the basis of having undergone testing. The post-course survey also asked students who underwent the testing whether they made any behavioral changes based on the results, such as lifestyle changes or making appointments with doctors. Some initial behavior changes were reported. Yet in a previous study involving face-to-face interviews with the same students, no behavior changes were reported six months after the end of the course.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our medical students / training section for the latest news on this subject.

Other Stanford authors included Konrad Karczewski, a bioinformatics PhD student, and Louanne Hudgins, MD, professor of pediatrics and of medical genetics.

Stanford University Medical Center

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Stanford University Medical Center. "Greater success in personalized medicine class by students who underwent genetic testing." Medical News Today. MediLexicon, Intl., 25 Jul. 2013. Web.
26 Jul. 2013. APA

Please note: If no author information is provided, the source is cited instead.


'Greater success in personalized medicine class by students who underwent genetic testing'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam). We reserve the right to amend opinions where we deem necessary.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here